Medpace Holdings Inc. (MEDP)$432.80
Market Cap: 8.64 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Medpace Holdings Inc. (MEDP).
HEALTHCARE
DIAGNOSTICS & RESEARCH
DCF ready
Valuation
11.9x
EV/FCF, 8.4% FCF yield
Quality
98.3%
ROIC, 26.9% FCF margin
Growth
22.3%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 0.7x current ratio
Superinvestors
3
Top: Francois Rochon (4.5%)
Strengths to research
- Revenue compounded at 22.3% over five years.
- Free cash flow compounded at 24.6% over five years.
- Return on equity is strong at 98.3%.
- Free cash flow margin is healthy at 26.9%.
Watchouts
- Current ratio is below 1 at 0.7x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for MEDP.
Grade A
91
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| MEDP Target | Medpace Holdings Inc. | $8.6B | 28.3x | 11.9x | 98.3% | 22.3% | 26.9% | N/A | -0.9x | N/A |
| ICLR | ICON plc | $11.4B | 12.3x | 9.7x | 8.3% | 24.2% | 13.5% | N/A | -0.3x | N/A |
| ERFSF | Eurofins Scientific SE | $11.5B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ILMN | Illumina Inc. | $12.4B | 26.5x | 11.8x | 31.2% | 6.0% | 21.4% | 66.1% | -1.3x | N/A |
| CRL | Charles River Labs | $5.9B | -55.1x | 10.9x | -4.6% | 6.5% | 12.9% | N/A | -0.5x | N/A |
| DGX | Quest Diagnostics | $19.8B | 22.3x | 18.5x | 7.7% | 3.2% | 12.3% | N/A | 2.5x | N/A |
| LH | Labcorp Holdings Inc. | $20.7B | 24.8x | 16.7x | 10.2% | -0.0% | 8.6% | 28.8% | -0.3x | N/A |
| NTRA | Natera Inc. | $21.4B | -133.7x | 186.2x | -12.2% | 42.6% | 4.7% | N/A | N/A | N/A |
| MTD | Mettler-Toledo International Inc. | $22.7B | 26.2x | 29.2x | 42.1% | 5.5% | 21.1% | 59.4% | N/A | N/A |
Financial Charts
No financial data available for MEDP (annual).
3 superinvestors own MEDP
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Francois Rochon Giverny Capital | 256,081 | $123M | 4.50% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 85,720 | $41M | 0.42% | 0.0% |
| Terry Smith Fundsmith | 62,668 | $30M | 0.23% | 0.0% |